Opioid-mediated muscle afferents inhibit central motor drive and limit peripheral muscle fatigue development in humans. - Wikidata - awgldk - TriplyDB

Opioid-mediated muscle afferents inhibit central motor drive and limit peripheral muscle fatigue development in humans.

Opioid-mediated muscle afferents inhibit central motor drive and limit peripheral muscle fatigue development in humans.

http://www.wikidata.org/entity/Q44340694

about

Fatigue is a Brain-Derived Emotion that Regulates the Exercise Behavior to Ensure the Protection of Whole Body Homeostasis Neurophysiological Determinants of Theoretical Concepts and Mechanisms Involved in Pacing Nutritional interventions to augment resistance training-induced skeletal muscle hypertrophy Significance of Group III and IV muscle afferents for the endurance exercising human Neuromuscular consequences of an extreme mountain ultra-marathon Are There Critical Fatigue Thresholds? Aggregated vs. Individual Data.Group III/IV muscle afferents impair limb blood in patients with chronic heart failure.An official American Thoracic Society/European Respiratory Society statement: update on limb muscle dysfunction in chronic obstructive pulmonary disease.Impact of pulmonary system limitations on locomotor muscle fatigue in patients with COPD.The role of active muscle mass in determining the magnitude of peripheral fatigue during dynamic exercise.Factors affecting the regulation of pacing: current perspectives Group III and IV muscle afferents contribute to ventilatory and cardiovascular response to rhythmic exercise in humans.Psychophysical stress increases the expression of phospho-CREB, Fos protein and neurokinin-1 receptors in superficial laminae of trigeminal subnucleus caudalis in female rats.Disparity in regional and systemic circulatory capacities: do they affect the regulation of the circulation?Interaction of central and peripheral factors during repeated sprints at different levels of arterial O2 saturation.Prior heat stress effects fatigue recovery of the elbow flexor muscles.Myoelectrical manifestation of fatigue less prominent in patients with cancer related fatigue Autonomic responses to exercise: group III/IV muscle afferents and fatigue.Humans In Hypoxia: A Conspiracy Of Maladaptation?!Five-Kilometers Time Trial: Preliminary Validation of a Short Test for Cycling Performance Evaluation.Intrathecal fentanyl blockade of afferent neural feedback from skeletal muscle during exercise in heart failure patients: Influence on circulatory power and pulmonary vascular capacitance Exploring the performance reserve: Effect of different magnitudes of power output deception on 4,000 m cycling time-trial performance.Improved Ventilatory Efficiency with Locomotor Muscle Afferent Inhibition is Strongly Associated with Leg Composition in Heart Failure Aging alters muscle reflex control of autonomic cardiovascular responses to rhythmic contractions in humans.Muscle mass and peripheral fatigue: a potential role for afferent feedback?Central and Peripheral Fatigue During Resistance Exercise - A Critical Review.Cortical and segmental excitability during fatiguing contractions of the soleus muscle in humans Control and sensation of breathing during cycling exercise in hypoxia under naloxone: a randomised controlled crossover trial.Peripheral fatigue limits endurance exercise via a sensory feedback-mediated reduction in spinal motoneuronal output.AltitudeOmics: on the consequences of high-altitude acclimatization for the development of fatigue during locomotor exercise in humans.Ascorbate infusion increases skeletal muscle fatigue resistance in patients with chronic obstructive pulmonary disease.Mechanism of augmented exercise hyperpnea in chronic heart failure and dead space loading.EFFECT OF DIFFERENT FOAM ROLLING VOLUMES ON KNEE EXTENSION FATIGUE.No Critical Peripheral Fatigue Threshold during Intermittent Isometric Time to Task Failure Test with the Knee Extensors.Group III/IV locomotor muscle afferents alter motor cortical and corticospinal excitability and promote central fatigue during cycling exercise.Pulmonary system limitations to endurance exercise performance in humans Exogenously applied muscle metabolites synergistically evoke sensations of muscle fatigue and pain in human subjects.No Influence of Transcutaneous Electrical Nerve Stimulation on Exercise-Induced Pain and 5-Km Cycling Time-Trial Performance.Oxidative stress and COPD: the effect of oral antioxidants on skeletal muscle fatigue.MAXIMUM REPETITION PERFORMANCE AFTER DIFFERENT ANTAGONIST FOAM ROLLING VOLUMES IN THE INTER-SET REST PERIOD.

P2860

Q21129258-95E14C24-B98D-4E84-AADB-D3911CB3CA90 Q22252564-06EC732F-26EE-48AE-A9B5-F86E774A7669 Q26782957-B0B9CDE3-0945-4786-B7DA-649AC49A43CB Q27012787-99A9DFB9-8BAD-4246-B8EA-63927086358A Q28477233-271F531B-7B0F-4FDC-AEBD-588AD6B6A430 Q31130893-D3430D9F-AA09-4DC4-90A1-6E830889119B Q33822116-A375D618-B116-4355-910F-8C13871244DA Q33901722-80E5C625-EE73-476B-8362-995BD513A05F Q33994968-5EA77F52-DFA8-4E15-BA9F-F930F38A5269 Q34158019-EF65C29E-E2A1-45A3-BBFE-20236E91022F Q34166959-2764B0D5-D37F-4AE6-AED3-4B484B86E645 Q34236432-797EFFD3-D3D3-4088-9DE8-162CD99FAF52 Q34258815-7E130EB9-8F5D-402A-BF1F-D4CACCA50541 Q34447030-54DF8DD1-B5FE-4DAE-9E40-38574C60CC8D Q35025426-4721A916-650F-45BD-8758-A232B500E842 Q35051354-CB7A58BD-65FE-4390-9D02-28FF74E08280 Q35082550-5200C943-FA71-46BF-A4C9-F4187C9762B6 Q35108132-3D82EEBB-7CF2-4688-80A8-45FD73650D6F Q35817898-D8B9BF9E-B3B6-4D24-8C9D-2B2996F8C0CE Q36123818-AEE95E5E-589D-401D-A504-FBCA7F594E5C Q36157352-A87E37DC-4707-4F10-9B23-E021BCF994D8 Q36302287-D2F095C9-AAE7-48B0-BF87-301B2D5A4F2C Q36307483-570F7E7C-F8E8-46CA-8D49-A084AAA2051E Q36339455-EE806EE7-1928-44D7-8C07-7F06223452BE Q36360680-1CF9D16F-A7A5-4128-A568-C16175169AB9 Q36490942-1375020D-EFA9-44AC-9998-F192D1E61DBB Q36845224-609D843E-B1C9-443A-A99D-EF088A966D91 Q37008454-F9A32E87-4B37-4BB2-9706-43476E84F9FE Q37094184-1FBA8F57-5299-4A57-B27D-0D85954D73FF Q37147199-91FE90E2-F2AF-4C7B-8AE4-EDF48698B601 Q37346053-5CAAF266-9663-4F3C-8B79-3A2C99079BC5 Q37467759-4A2C1412-705A-4F92-BC6B-B7B35DCB8865 Q37507863-FF0DD5D7-7876-4A02-83C6-B2F38E05AFF2 Q37512152-520BC6A0-8C0C-465B-8EE5-3D09A2913C09 Q37589344-AF2DE337-8A01-43D5-9750-13E7EBBFC323 Q37602794-B10E2FB1-69EF-4F13-8AE7-A8E7686FD56E Q37624800-D54B1ED9-1E09-4788-A776-331EB4EE28AD Q37627129-300EC250-9082-4F49-8C4B-9A1ECD0CB034 Q37627485-5309C050-1A00-460D-82E0-8B778C8EC9CC Q37628164-C023CBCC-6E83-4EF4-8978-AC7A027D0E3B

P2860

Opioid-mediated muscle afferents inhibit central motor drive and limit peripheral muscle fatigue development in humans.

http://www.wikidata.org/entity/Q44340694

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年学术文章

@wuu

2008年学术文章

@zh-cn

2008年学术文章

@zh-hans

2008年学术文章

@zh-my

2008年学术文章

@zh-sg

2008年學術文章

@yue

2008年學術文章

@zh

2008年學術文章

@zh-hant

name

Opioid-mediated muscle afferen ...... fatigue development in humans.

@en

Opioid-mediated muscle afferen ...... fatigue development in humans.

@nl

type

label

Opioid-mediated muscle afferen ...... fatigue development in humans.

@en

Opioid-mediated muscle afferen ...... fatigue development in humans.

@nl

prefLabel

Opioid-mediated muscle afferen ...... fatigue development in humans.

@en

Opioid-mediated muscle afferen ...... fatigue development in humans.

@nl

P1433

Q44340694-0522A09B-AFDB-4FAA-B3CD-5FFD9D87F9B8

P1476

Q44340694-21BCA81B-7437-4A08-99CF-8A16067136C2

P2093

Q44340694-5A00E75A-87BD-4229-A4CC-C7B0349B0E9E

Q44340694-868F94B9-A339-4BD6-A432-8FB98992B3C9

Q44340694-BE5AD81D-DA43-4549-97C4-F7593B16CE7F

Q44340694-CE6FFC83-59B9-4B0F-8ECA-95131BF4E315

P2860

Q44340694-0626C13A-0DDF-483D-8A7B-17936B63A71A

Q44340694-0E6EC093-E941-41CE-AF72-290BAF98FD34

Q44340694-123C82D3-E1E0-4EEA-ACEF-D15AA74C045C

Q44340694-18F40316-B196-49D5-96AF-EAB16D9C84B8

Q44340694-2AF3CA61-3FF2-4421-AB20-55497AEC4997

Q44340694-2C63F226-C2A1-410B-BE7C-F34285A90AFE

Q44340694-2CBAD476-4119-42E7-8F1C-BCD0B8B16F97

Q44340694-2FD7AEC9-64F7-4D71-B063-BFEA5D0FE421

Q44340694-3408844D-8DC3-4D40-A4FA-CBF96D3A703D

Q44340694-51C90ABD-C75A-4B32-A7BB-DEAF01844AE0

P304

Q44340694-72DF1279-CADC-4038-8660-5765168ABE63

P31

Q44340694-012A31CD-F4B4-4782-ADBD-713DA1A19545

P356

Q44340694-47C64735-6E01-4BD6-A302-4E89C8C23D3A

P407

Q44340694-9A275340-F901-429D-9F0B-04FF22B7343C

P433

Q44340694-F7F248C5-1B4E-47D5-9FF6-93944D77081A

P478

Q44340694-90BF7A8C-B541-4B9B-A124-7DDA57880009

P50

Q44340694-BAACE190-7D3F-4FC9-A1E0-6F0B89C03815

P577

Q44340694-8F4A6B9A-0857-48F2-A359-2373D8142F78

P5875

Q44340694-15041C0E-44CF-405F-AD66-01B521857199

P698

Q44340694-4F730154-D89D-4B9A-98C1-372F7E63E113

P921

Q44340694-AB624259-DFA3-4420-90F3-018CE977B615

P932

Q44340694-9A607715-4584-4671-980F-AECC00B3B6FB

P356

JPHYSIOL.2008.163303

P1433

The Journal of Physiology

P1476

Opioid-mediated muscle afferen ...... fatigue development in humans

@en

P2093

David F Pegelow

http://www.w3.org/2001/XMLSchema#string

Jerome A Dempsey

http://www.w3.org/2001/XMLSchema#string

Joshua J Sebranek

http://www.w3.org/2001/XMLSchema#string

Lester T Proctor

http://www.w3.org/2001/XMLSchema#string

P2860

Spinal and supraspinal factors in human muscle fatigue

Neurobiology of muscle fatigue

Subarachnoid sufentanil for early postoperative pain management in orthopedic patients: a placebo-controlled, double-blind study using spinal microcatheters.

Intrathecally applied morphine inhibits nociceptive C fiber input to the primary somatosensory cortex (SI) of the rat.

Convective oxygen transport and fatigue.

The cross-bridge cycle and skeletal muscle fatigue.

The extraction of neural strategies from the surface EMG.

Afferent pain pathways: a neuroanatomical review.

Cerebral perturbations provoked by prolonged exercise.

Multiple spinal pathways mediate cutaneous nociceptive C fibre input to the primary somatosensory cortex (SI) in the rat.

P304

271-283

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1113/JPHYSIOL.2008.163303

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

587

http://www.w3.org/2001/XMLSchema#string

P50

P577

2008-11-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23479449

http://www.w3.org/2001/XMLSchema#string

P698

19015193

http://www.w3.org/2001/XMLSchema#string

P921

P932

2670040

http://www.w3.org/2001/XMLSchema#string